This investment in the development of a new short-stay surgical facility will extend the no-gap treatment model for eligible patients and reinforces Medibank's ongoing commitment to supporting healthcare providers to improve patient experience and ensuring the affordability of the private healthcare system in Australia.
Corrs drew on expertise from around the firm with partners Sandy Mak and Shabarika Ajitkumar (Corporate), Nathaniel Popelianski (Property and Real Estate), Mark McCowan (Competition) and Helen Clarke (Intellectual Property) advising Medibank on all aspects of the transaction.
Commenting on the matter, Corrs partner Shabarika Ajitkumar said: "We are delighted to have worked with Medibank on this strategic investment. It recognises Medibank's continued commitment to delivering innovative new models of care that are patient-centric and provide patients with greater choice in how their care is delivered."
Sandy Mak, Head of the Corrs Corporate/M&A team, added: "It was a privilege to have acted for Medibank on another key strategic transaction. It was once again a great team effort with multiple practice groups from across Corrs contributing to a successful outcome for the client."